drugset / Trial / NCT02566720

Amantadine and Functional Improvement Following ABI Measured by MRI Tractography; A Pilot Study

NCT02566720

NaSingle-groupOpen-label

Summary

This is a pilot study. The objective is to further understand the mechanism by which amantadine improves function in patients with persistent vegetative state and minimally conscious state. Specifically, the investigators will measure the size of the nerve fibers that mediate arousal (reticular activating system, or RAS) pre and post treatment on MRI tractography. MRI findings will be correlated with the Disability Rating Scale (DRS) score. The information gathered from this study will be used to formulate a larger clinical trial.

Timeline

Start
2016-01
Primary completion
2016-12
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Amantadine Unknown 200 mg Oral